INTRODUCTION
Interferons (IFNs) are cytokines that regulate cell proliferation and differentiation, and activate effector cells of the immune system (Platanias, 2005) . The first signalling pathway shown to be activated by IFNs is the JAK-STAT pathway, but it has become evident that other signalling cascades are required for the generation of pleiotropic responses to IFNs. These include the p38 signalling cascade (Katsoulidis et al, 2005) , pathways involving protein kinase C (PKC) isoforms (Uddin et al, 2002) or CRK proteins (Platanias, 2005) , and the phosphoinositide-3 kinase (PI(3)K) pathway (Platanias, 2005; van Boxel-Dezaire et al, 2006) . Recently, we have shown that type I IFNs activate a Jun N-terminal kinase (JNK)-specific signalling cascade-RAC1-MEKK1-MKK4-JNK-and that filamin B facilitates type I IFN signalling by acting as a scaffold that tethers RAC1 and the JNK cascade members (Jeon et al, 2008) .
Filamins are actin-binding proteins that comprise a family of three members: filamin A, B and C (Stossel et al, 2001; van der Flier & Sonnenberg, 2001 ). These filamin isoforms have a crucial function in crosslinking cortical actin filaments into a dynamic, three-dimensional structure. Filamins also interact with more than 30 cellular proteins of functional diversity (Stossel et al, 2001) , suggesting that filamins function as molecular scaffolds by connecting and coordinating various cellular processes.
The interferon-stimulated gene 15 (ISG15) is the first reported ubiquitin-like protein (Haas et al, 1987) and its expression and conjugation to proteins are induced by type I IFNs (Der et al, 1998) . The ubiquitin-activating enzyme E1-like (UBE1L) is an E1 ISG15-activating enzyme (Yuan & Krug, 2001) ; ubiquitin E2 enzymes, ubiquitin-conjugating enzyme in human (UBCH)6 and UBCH8, also function as ISG15-conjugating enzymes (Kim et al, 2004; Zhao et al, 2004) ; ubiquitin E3 ligases, HECT domain and RLD5 (HERC5) and estrogen-responsive finger protein (EFP), also act as ISG15 E3 ligases (Wong et al, 2006; Zou & Zhang, 2006) ; and ubiquitin-specific processing protease 43 (UBP43) acts as a deISGylating enzyme (Malakhov et al, 2002) . Appropriately, all of the enzymes identified in the ISGylation pathway are induced in a coordinated manner by type I IFNs.
At least 200 putative ISG15 target proteins have been identified so far (Zhao et al, 2005) . Many of them have crucial functions in the type I IFN response, and include JAK1, STAT1, RIG-I and the antiviral effector proteins MxA, PKR and RNase L (Zhao et al, 2005; Arimoto et al, 2008; Kim et al, 2008) . ISG15 has been reported to prevent virus-mediated degradation of interferon regulatory factor 3 (IRF3), thereby increasing the induction of IFNb expression (Lu et al, 2006) . Other reports support a role for ISG15 in mediating resistance to the Ebola virus through ISGylation of NEDD4 (Malakhova & Zhang, 2008; Okumura et al, 2008) ; however, it remains unknown how ISGylation of target proteins affects their cellular function in the control of IFN-mediated signalling pathway. Here, we show that filamin B is modified by ISG15 in response to type I IFNs and that this modification blocks its scaffold function, leading to the abrogation of the IFN-induced JNK signalling pathway. These results establish that ISGylation of filamin B acts as a negative feedback regulatory gate for the desensitization of type I IFN-induced JNK signalling.
RESULTS AND DISCUSSION Filamin B is a target for ISGylation
Type I IFNs induce the accumulation of ISG15 and its conjugating enzyme system. In addition, filamin B has been identified as a putative target for ISGylation (Zhao et al, 2005) . To determine whether filamin B could indeed be modified by ISG15, A549 cells were cultured with or without IFNb. Immunoprecipitation analysis revealed that endogenous filamin B-but not filamin A-was ISGylated only when cells were treated with IFNb or IFNa (Fig 1A; data not shown). Then, we examined whether overexpressed filamin B could also be ISGylated. The carboxy-terminal region from hinge-1 to repeat 24 (H1-R24; see Fig 2A) was expressed with ISG15 (Flag-ISG15gg) or its mutant form having the C-terminal Ala-Ala in place of Gly-Gly (Flag-ISG15aa). Henceforth, the C-terminal H1-R24 region of filamin B is referred to as c-filamin B. Expression of ISG15gg, but not ISG15aa, resulted in c-filamin B ISGylation (Fig 1B) , indicating that the C-terminal glycine is required for filamin B ISGylation. In addition, coexpression of UBP43 led to deISGylation of c-filamin B (Fig 1C) . Taken together, these results indicate that filamin B is an ISGylation target.
Lys 2467 of filamin B is the ISGylation site
To determine the ISGylation site, various deletions of filamin B were expressed in HeLa cells with Flag-ISG15 (Fig 2A) . The mutants containing R22-24 were ISGylated, whereas H1-R21 and H2-R24 were not. Neither actin-binding domain-R7 (ABD-R7) nor R8-15 was ISGylated. These results indicate that the ISGylation site lies within R22-23. Each of the 13 lysine residues in the R22-23 region of HisMax-R22-24 was replaced by arginine. These mutants were expressed in HeLa cells with Flag-ISG15 followed by pull down with nitrilotriacetic acid (NTA) resins. Immunoblot of the precipitates with Flag antibodies revealed that the K2467R mutation, but not the other mutations, blocked the appearance of a 62-kDa band (indicated by R22-24-ISG), suggesting that Lys 2467 is the ISGylation site (Fig 2B) . Immunoblot of the same precipitates with Xpress antibodies again showed that the K2467R mutation blocked the appearance of the 62-kDa band; however, it also blocked the appearance of an additional 55-kDa band (indicated by a dot), which was detected in the precipitates from cells expressing all other mutants and wild-type R22-24. To clarify whether Lys 2467 acts as the ISGylation site, we built the K2467R mutation into a full-length filamin B. Fig 2C shows that the K2467R mutation prevents the ISGylation of filamin B. Therefore, we concluded that Lys 2467 in filamin B is the ISG15 acceptor site, although the nature of the 55-kDa protein remains unknown.
Filamin B ISGylation blocks its scaffold function
Filamin B acts as a scaffold that tethers RAC1 and a JNK-specific mitogen-activated protein kinase (MAPK) module-MEKK1, MKK4 and JNK1-and thereby facilitates type I IFN-induced JNK activation (Jeon et al, 2008) . To determine whether ISGylation of filamin B influences its function as a scaffold, RAC1 and the JNK cascade members were expressed in HeLa cells with c-filamin B or its K2467R mutant (henceforth referred to as c-K2467R). Coexpression of ISG15 prevented the interaction of RAC1 with c-filamin B, but not with c-K2467R (Fig 3A) . In addition, ISG15aa expression showed little or no effect on the interaction of RAC1 with c-filamin B (Fig 3B) . Similarly, the interaction of MEKK1 and MKK4 with c-filamin B, but not with c-K2467R, was markedly reduced by coexpression of . E1 and E2 were also expressed by co-transfection of cells with pcDNA-UBE1L and pcDNA-Myc-UBCH8, respectively. Cell lysates were immunoprecipitated with Flag antibodies, followed by immunoblot with Xpress antibodies. Cell lysates were also subjected to NTA pull-down (PD: NTA) under denaturing conditions followed by immunoblot with Xpress or Flag antibodies. (C) HM-c-filamin B, Flag-ISG15 and UBP43 were expressed with E1 and E2 as indicated. Cell lysates were then subjected to NTA pull-down as in (B). c-Filamin B, the carboxy-terminal H1-R24 region of filamin B; IFN, interferon; ISG, interferon-stimulated gene; NTA, nitrilotriacetic acid; UBC, ubiquitin-conjugating enzyme; UBE1L, ubiquitin-activating enzyme E1-like; UBP43, ubiquitin-specific processing protease 43.
Filamin B ISGylation blocks JNK signalling Y.J. Jeon et al ISG15 (Fig 3D,E) . By contrast, the interaction of c-filamin B with JNK1 was not affected regardless of ISG15 coexpression ( Fig 3C) . These results indicate that ISGylation of filamin B prevents its ability to interact with the upstream activators of the JNK cascade. To confirm whether type I IFN-induced filamin B ISGylation blocks the interaction between filamin B and JNK cascade members, M2 cells, having a negligible amount of filamin B (Jeon et al, 2008) , were complemented with HisMax-tagged full-length filamin B or K2467R followed by IFNa treatment. The interaction of filamin B with endogenous RAC1, MEKK1 and MKK4 increased until about 12 h after IFNa treatment and gradually decreased thereafter, concomitant with an increase in the level of ISGylated filamin B (Fig 3F) . However, K2467R persistently interacted with the JNK cascade members even when ISGylated cellular proteins reached a maximal level. To confirm whether ISGylation of filamin B is responsible for the prevention of its interaction with the JNK activators, an UBE1L-specific short hairpin RNA (shUBE1L) was transfected with M2 cells. shUBE1L, but not a control vector (shControl), abolished the negative effect of filamin B ISGylation on IFNa-induced interaction of filamin B with RAC1, MEKK1 and MKK4 (Fig 3G) . These results indicate that the ISGylation of filamin B abrogates its scaffold function.
Filamin B ISGylation inhibits IFNa-induced JNK signalling
As ISGylation abrogates the scaffold function of filamin B, we examined its effect on type I IFN-induced JNK activation. Coexpression of ISG15 led to a marked decrease in the activation of JNK in M2 cells complemented with c-filamin B, but not in c-K2467R-complemented cells (Fig 4A) , indicating that ISGylation of filamin B abrogates its ability to promote type I IFN-induced JNK activation. In addition, ISG15 expression strongly inhibited the ability of c-filamin B, but not of c-K2467R, in the promotion of IFNa-induced RAC1 activation (Fig 4B) . These results indicate that ISGylation of filamin B blocks its ability to promote IFNa-induced RAC1 activation. Next, we examined the effect of c-filamin B ISGylation on sequential activation of the JNK cascade. MEKK1-mediated phosphorylation of MKK4 was enhanced by c-filamin B or c-K2467R ( Fig 4C) ; however, coexpression of ISG15 blocked the promotion of MKK4 activation by c-filamin B, but not by c-K2467R. Similarly, MKK4-mediated activation of JNK1 was increased by c-filamin B or c-K2467R, and coexpression of ISG15 abolished the stimulatory effect of c-filamin B, but not of c-K2467R (Fig 4D) . In addition, c-filamin B or c-K2467R could enhance MEKK1-mediated activation of JNK1, and the stimulatory effect of c-filamin B, but not of c-K2467R, was prevented by ISG15 coexpression (Fig 4E) . Taken together, these results indicate that ISGylation of filamin B prevents its ability to promote the sequential activation of the JNK cascade-MEKK1-MKK4-JNK1-by blocking its scaffold function.
As filamin B accelerates IFNa-induced apoptosis through the activation of JNK (Jeon et al, 2008) , we examined the effect of filamin B ISGylation on JNK-mediated apoptosis. Coexpression of ISG15 led to a decrease in the levels of TRAIL-R1 (tumour necrosis factor-related apoptosis-inducing ligand) and in the cleavage of PARP (poly (ADP-ribose) polymerase) in M2 cells complemented with c-filamin B, but not in c-K2467R-complemented cells (Fig 4F) , indicating that ISGylation of filamin B blocks its ability to promote IFNa-induced apoptosis. To confirm this finding, M2 After incubation with IFNa, cell lysates were subjected to NTA pull-down followed by immunoblot analysis. They were also probed directly with ISG15 or UBE1L antibodies. c-Filamin B, the carboxy-terminal H1-R24 region of filamin B; HA, haemagglutinin; HM, HisMax; IFN, interferon; IgG, immunoglobulin G; ISG, interferon-stimulated gene; JNK, Jun N-terminal kinase; NTA, nitrilotriacetic acid; Sh, Short hairpin; UBE1L, ubiquitin-activating enzyme E1-like; wt, wild type. An important question is how ISGylation of a small fraction of filamin B could inhibit its ability to promote the type I IFN-induced JNK pathway. However, if the small fraction of ISGylated filamin B is localized to a functionally unique subcellular site, the inhibitory mechanism could operate efficiently. Filamin B sequesters RAC1 and JNK cascade members in membrane ruffles for facilitating type I IFN signalling (Jeon et al, 2008) ; therefore, we examined whether filamin B could also recruit UBCH8, an E2 for ISG15, to membrane ruffles for facilitating the ISGylation of filamin B. In HeLa cells, UBCH8 was present throughout the cytoplasm and the nucleus; however, on filamin B coexpression a significant portion of UBCH8 was recruited to membrane ruffles where filamin B is also concentrated with actin ( Fig 5A) . These results suggest that filamin B ISGylation occurs in membrane ruffles, which should result in the prevention of filamin B scaffold function.
Fig 5B shows a model for the regulatory role of filamin B ISGylation in the type I IFN-induced JNK signalling pathway. Binding of IFNa/b to the type I IFN receptor (IFNAR) induces a successive activation of the RAC1-and JNK-specific cascade through phospho-relay reactions, resulting in JNK activation and thus in JNK-mediated apoptosis. On the accumulation of ISG15 and its conjugation system as a late response to type I IFNs, ISGylation of filamin B proceeds and blocks its role as a scaffold in tethering RAC1 and JNK cascade members, thus desensitizing type I IFN-induced JNK signalling.
Apoptosis acts as a crucial mechanism for the killing of host cells on viral infection. IFNs promote not only apoptosis but also cell survival against various proapoptotic stimuli such as viral infection. Thus, the antiviral action induced by IFNs could be due to the protection of uninfected cells against virus-induced apoptosis, as well as to the direct killing of infected cells. For example, IFNs promote the survival of activated T cells (Marrack et al, 1999) , protect CD4 þ cells from human immunodeficiency virus (HIV)-induced cell death (Cremer et al, 1999) and protect lymphoblastoid cells from cell death induced by viral infection (Einhorn & Grander, 1996) . In addition, the IFNb transduction of peripheral blood lymphocytes from uninfected or HIV-infected donors has been shown to inhibit viral replication and increase the survival of CD4 þ cells (Vieillard et al, 1997) . In this respect, we suggest that the control of JNK-mediated apoptosis by ISGylation of filamin B in response to type I IFNs could be a crucial mechanism for the survival of uninfected bystander cells and thus for antiviral action. 
METHODS
RAC1 activation assay. RAC1 activation was assayed as described previously (Benard et al, 1999) . Briefly, the GTPase-binding domain of human PAK1 (p21-activated kinase 1) was expressed in Escherichia coli as a glutathione S-transferase (GST) fusion. Cells were serum-starved for 3 h, treated with 10,000 U/ml of IFNa for 0.5 h and lysed. Cell lysates were incubated for 1 h with 5 mg of GST-PBD, followed by a pull-down with glutathione-Sepharose.
Precipitates were subjected to immunoblot with RAC1 antibodies.
Immunoprecipitation and pull-down analysis. For immunoprecipitation, cells were lysed in 50 mM Tris-HCl (pH 8), 150 mM NaCl, 1% Triton X-100 or 0.5% NP-40, 1 mM PMSF and 1 Â protease inhibitor cocktail (Roche, Mannheim, Germany). Cell lysates were incubated with the appropriate antibodies for 2 h at 4 1C and then with 50 ml of 50% slurry of protein A-Sepharose for 1 h. Cell lysates prepared as above were also subjected to pull-down with NTA resins. For pull-down analysis under denaturing conditions, cell lysates were prepared in 0.1 M NaH 2 PO 4 /Na 2 HPO 4 buffer (pH 7.4) containing 8 M urea and 5 mM imidazole. After incubation with NTA resins, precipitates were washed with the same buffer containing 5 mM imidazole followed by SDS-PAGE.
In vitro kinase assay. For assaying JNK activity, cell lysates were incubated for 5 h with GST-cJun bound to glutathione-agarose.
Precipitates were washed twice with 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin and 1 mM PMSF. They were again washed with buffer-A consisting of 25 mM Tris-HCl (pH 7.5), 5 mM b-glycerophosphate, 2 mM DTT, 0.1 mM Na 3 VO 4 and 10 mM MgCl 2 . After washing, the precipitates were incubated in buffer-A containing 0.2 mM ATP for 30 min at 30 1C. The samples were resolved by SDS-PAGE, and phosphoproteins were visualized by immunoblot with the p-cJun antibody. For assaying MEKK1 activity, cell lysates were immunoprecipitated with the MEKK1 antibody. Precipitates were incubated with 2 mg GST-MKK4 as a substrate in buffer-A containing 0.2 mM ATP for 30 min at 30 1C. The samples were then resolved by SDS-PAGE, and phosphoproteins were visualized by immunoblot with the p-MKK4 antibody.
For other methods, see the supplementary information online. Supplementary information is available at EMBO reports online (http://www.emboreports.org)
